Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rhodium Catalyzed C H Activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113620795A details a novel Rh-catalyzed route to benzocycloheptenones. This method offers mild conditions, air stability, and high yields for complex pharmaceutical intermediates.
Patent CN113735770B details a novel Rh-catalyzed route to 1-aminoisoquinolines using vinylene carbonate, offering safer reagents and improved atom economy for industrial API manufacturing.
Patent CN116444503A details a rhodium-catalyzed route to chroman derivatives using pyridine triazoles, offering mild conditions and high purity for pharmaceutical manufacturing.
Patent CN109761875B reveals a high-yield Rh-catalyzed method for indole-3-carboxamides, offering cost-effective manufacturing solutions for pharmaceutical intermediates.
Efficient synthesis of fused polycyclic compounds via Rh-catalysis. Cost-effective pharmaceutical intermediate manufacturing with high purity and scalability for global supply chains.
Patent CN110283180B reveals a mild Rhodium-catalyzed route to pyridine[3,4-c]coumarins, offering reliable pharmaceutical intermediate suppliers a cost-effective manufacturing solution.
Patent CN115057808A reveals a green Rh-catalyzed method for Z-isoindolinones. High stereoselectivity, no oxidants. Ideal for pharma intermediates supply.
Novel rhodium-catalyzed method offers high purity carbazole intermediates with scalable supply chain advantages for global pharmaceutical and electronic chemical manufacturing.
Patent CN106977445B details a mild, one-pot Rh(III)-catalyzed synthesis of benzo[a]carbazoles, offering significant cost reduction and supply chain reliability for electronic chemical manufacturing.
Novel Rh-catalyzed method for 1,3-benzodiazepines with anticancer activity. Efficient route for pharmaceutical intermediates offering cost reduction.
Patent CN116003326A details a novel Rh-catalyzed one-pot synthesis of trifluoromethyl indazoles. This method offers mild conditions, broad substrate scope, and significant cost reduction in API manufacturing.
Patent CN111217737B details a novel Rhodium-catalyzed tandem reaction for synthesizing bioactive indane scaffolds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel Rh-catalyzed C-H activation method for high-purity benzothiazole intermediates. Offers cost reduction and scalable supply chain solutions for pharmaceutical manufacturing partners.
Novel Rh-catalyzed one-pot synthesis for 1,9-diazaphenalene derivatives. High yield, scalable process for OLED and pharma intermediates.
Patent CN112851674B reveals a novel rhodium-catalyzed double dehydrogenative coupling method for polysubstituted pyrroles, offering high efficiency and functional group diversity for industrial applications.
Novel Rh-catalyzed C-H activation for 3-aminoindanones. High yield, atom economy, scalable pharma intermediate manufacturing.
Patent CN115636829B reveals a novel Rh-catalyzed synthesis for high-purity benzo[1,8]naphthyridine compounds, offering significant supply chain and cost advantages for electronic chemical manufacturing.
Patent CN106946881A reveals a Rh-catalyzed one-pot route to amino-substituted naphthoquinazinones, offering mild conditions and broad substrate scope for cost-effective manufacturing.
Novel rhodium-catalyzed method for trifluoromethyl benzo naphthyridine. High yield, scalable process for organic luminescent materials supply chain.
Patent CN110746353B reveals a one-step rhodium-catalyzed cyclization for isoquinolinones and isocoumarins, offering significant cost reduction in pharmaceutical intermediate manufacturing.